InvestorsObserver
×
News Home

Is Imv Inc (IMV) Stock at the Top of the Biotechnology Industry?

Monday, December 06, 2021 10:08 AM | InvestorsObserver Analysts

Mentioned in this article

Is Imv Inc (IMV) Stock at the Top of the Biotechnology Industry?

Imv Inc (IMV) is around the middle of the Biotechnology industry according to InvestorsObserver. IMV received an overall rating of 40, which means that it scores higher than 40 percent of all stocks. Imv Inc also achieved a score of 54 in the Biotechnology industry, putting it above 54 percent of Biotechnology stocks. Biotechnology is ranked 89 out of the 148 industries.

Overall Score - 40
IMV has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on IMV!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Imv Inc Stock Today?

Imv Inc (IMV) stock is trading at $1.40 as of 10:06 AM on Monday, Dec 6, a gain of $0.03, or 2.19% from the previous closing price of $1.37. The stock has traded between $1.34 and $1.41 so far today. Volume today is light. So far 90,163 shares have traded compared to average volume of 600,841 shares. Click Here to get the full Stock Report for Imv Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App